ResearchMoz

Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-03-21
No. Of Pages » 96
   
 This report provides an in-depth analysis and market forecast for the global pharmacy automation market for the period 2012 – 2018. The report provides details of the several pharmacy automation devices currently available in the market along with the impact of these machines on modern pharmacies in terms of efficiency, reduction in error and speed. The report also highlights the unique connection of pharmacy automation devices with a number of other markets such as the E-prescription market and its role in the growth of pharmacy automation.  
   
 The scope of the report includes competitive analysis of major market segments based on end users, technology and of different regional markets such as Europe, North America, Asia-Pacific and the rest of the world. This...
Table of content

Chapter 1 Preface
1.1 Report description
1.2 Pharmacy automation systems: market segmentation
1.3 Research methodology
1.3.1 Sources
1.4 Assumptions

Chapter 2 Executive summary

Chapter 3 Pharmacy automation market analysis
3.1 Current market trends and future outlook
3.1.1 Benefits of pharmacy automation technologies
3.2 Role of IT applications in pharmacy automation
3.2.1 Clinical decision support system (CDSS)
3.2.2 Computerized physician order entry (CPOE)
3.2.3 E-prescribing
3.2.4 Electronic health record (EHR)
3.2.5 Interactive voice response (IVR)
3.3 Trends of IT applications in pharmacy automation
3.4 Market drivers
3.4.1 Increasing number of medication error deaths
3.4.2 Increasing drug prices and reducing reimbursement will increase the demand for drug dispensing systems to control pharmacy cost
3.4.3 Increasing awareness about benefits of automated systems among healthcare providers and pharmacists
3.4.4 Increasing per capita healthcare expenditure
3.5 Market restraints
3.5.1 High cost of implementation
3.5.2 Lack of awareness about benefits of pharmacy automation technologies
3.6 Market opportunities
3.6.1 Huge market opportunity in emerging market segments
3.6.2 Large market potential in replacement market
3.7 Market attractiveness
3.8 Porters five forces analysis for pharmacy automation technologies
3.8.1 Bargaining power of suppliers – Moderate to Moderate
3.8.2 Bargaining power of buyers – Moderate to Moderate
3.8.3 Threats from substitutes – Low to Low
3.8.4 Threat from new entrants - Low - Low
3.8.5 Degree of rivalry - High to High

Chapter 4 Pharmacy automation market analysis by application, 2012 – 2018
4.1 Market overview
4.1.1 Automated medication dispensing
4.1.1.1 Intorduction
4.1.1.2 Market trends and outlook
4.1.1.3 Market size and forecast
4.1.2 Automated packaging and labeling
4.1.2.1 Intorduction
4.1.2.2 Market trends and outlook
4.1.2.3 Market size and forecast
4.1.3 Automated storage and retrieval systems
4.1.3.1 Intorduction
4.1.3.2 Market trends and outlook
4.1.3.3 Market size and forecast
4.1.4 Automated compounding devices
4.1.4.1 Intorduction
4.1.4.2 Market trends and outlook
4.1.4.3 Market size and forecast
4.1.5 Table-top tablet counter
4.1.5.1 Intorduction
4.1.5.2 Market trends and outlook
4.1.5.3 Market size and forecast

Chapter 5 Pharmacy automation market analysis, by end users, 2012 – 2018
5.1 Market overview
5.1.1 Automation in hospital pharmacy
5.1.1.1 Intorduction
5.1.1.2 Market trends and outlook
5.1.1.3 Market size and forecast
5.1.2 Retail Pharmacy
5.1.2.1 Intorduction
5.1.2.2 Market trends and outlook
5.1.2.3 Market size and forecast

Chapter 6 Pharmacy automation market analysis, by geography, 2012 - 2018
6.1 Market overview
6.1.1 North America
6.1.1.1 Intorduction
6.1.1.2 Market trends and outlook
6.1.1.3 Market size and forecast
6.1.2 Europe
6.1.2.1 Intorduction
6.1.2.2 Market trends and outlook
6.1.2.3 Market size and forecast
6.1.3 Asia-Pacific
6.1.3.1 Intorduction
6.1.3.2 Market trends and outlook
6.1.3.3 Market size and forecast
6.1.4 Rest of the World
6.1.4.1 Intorduction
6.1.4.2 Market trends and outlook
6.1.4.3 Market size and forecast

Chapter 7 Key competitors analysis
7.1.1 Pharmacy automation market share analysis, 2011

Chapter 8 Company profile analysis
8.1 AmerisourceBergen Corporation
8.1.1 Business overview
8.1.2 Financial overview
8.1.3 Business strategies
8.1.4 Recent developments
8.2 McKesson Corporation
8.2.1 Business overview
8.2.2 Financial overview
8.2.3 Business strategies
8.2.4 Recent developments
8.3 CareFusion Corporation
8.3.1 Business overview
8.3.2 Financial overview
8.3.3 Business strategies
8.3.4 Recent developments
8.4 Health Robotics SRL
8.4.1 Business overview
8.4.2 Financial overview
8.4.3 Business Strategies
8.4.4 Recent developments
8.5 Cerner Corporation
8.5.1 Business overview
8.5.2 Financial overview
8.5.3 Business strategies
8.5.4 Recent developments
8.6 Kirby Lester
8.6.1 Business overview
8.6.2 Financial overview
8.6.3 Business strategies
8.6.4 Recent developments
8.7 Omnicell Inc
8.7.1 Business overview
8.7.2 Financial overview
8.7.3 Business strategies
8.7.4 Recent developments
8.8 Baxter International Inc.
8.8.1 Business overview
8.8.2 Financial overview
8.8.3 Business strategies
8.8.4 Recent developments
8.9 ScriptPro LLC
8.9.1 Business overview
8.9.2 Financial overview
8.9.3 Business strategies
8.9.4 Recent developments
8.10 Swisslog Holding Ltd
8.10.1 Business overview
8.10.2 Financial overview
8.10.3 Business strategies
8.10.4 Recent developments
8.11 Yuyama Co., Ltd
8.11.1 Business overview
8.11.2 Financial overview
8.11.3 Business strategies
8.12 Talyst Inc
8.12.1 Business overview
8.12.2 Financial overview
8.12.3 Business strategies
8.12.4 Recent developments

List of Tables

List of Tables

TABLE 1 Pharmacy automation systems – market snapshot
TABLE 2 Per capita healthcare expenditure in major countries, USD
TABLE 3 Pharmacy automation systems market value and forecast, by technology 2010 - 2018 (million)
TABLE 4 Global pharmacy automation systems market value and forecast, by end user 2010 - 2018 (million)
TABLE 5 Hospital pharmacy automation market value and forecast, by geography 2010 - 2018 (million)
TABLE 6 Retail pharmacy automation market value and forecast, by geography 2010 - 2018 (million)
TABLE 7 Global pharmacy automation systems market value and forecast, by geography, 2010 - 2018 (million)
TABLE 8 North America pharmacy automation systems market value and forecast, by technologies 2010 - 2018 (million)
TABLE 9 Europe pharmacy automation systems market value and forecast, by geography 2010 - 2018 (million)
TABLE 10 Asia-Pacific pharmacy automation systems market value and forecast, by geography 2010 - 2018 (million)
TABLE 11 Rest of the World automation systems market value and forecast, by geography 2010 - 2018 (million)
TABLE 12 Key players in the hospital pharmacy automation systems market,key brands, global presents, specialty
TABLE 13 Key players in retail pharmacy automation systems market, key brands, global presence, specialty

List of Figures

List of Figures

FIG. 1 Pharmacy automation technologies: market segmentation
FIG. 2 Pharmacy automation systems market, by geography 2011 (USD Million)
FIG. 3 Pharmacy automation technologies market attractiveness, by technologies 2010 – 2018 (USD million)
FIG. 4 Porter’s five forces analysis for pharmacy automation technologies market
FIG. 5 Automated medication dispensing technology market, 2010 – 2018 (USD million)
FIG. 6 Automated packaging and labeling market, 2010 – 2018 (USD million)
FIG. 7 Automated storage and retrieval systems market, 2010 – 2018 (USD million)
FIG. 8 Automated compounding devices market, 2010 – 2018 (USD million)
FIG. 9 Table-top tablet counter market, 2010 – 2018 (USD million)
FIG. 10 Pharmacy automation technologies market share, by geography 2011 & 2018 (%)
FIG. 11 Pharmacy automation systems market key players market share, 2011 (%)
FIG. 12 AmerisourceBergen Corporation: annual revenue, USD million, 2009 - 2011
FIG. 13 McKesson Corporation: annual revenue, USD million, 2009 - 2011
FIG. 14 CareFusion Corporation annual revenue, USD million, 2009 - 2011
FIG. 15 Health Robotics S.r.l annual revenue, USD million, 2009 - 2011
FIG. 16 Cerner Corporation: annual revenue, USD million, 2009 - 2011
FIG. 17 Omnicell Corporation: annual revenue, USD million, 2009 - 2011
FIG. 18 Baxter International Inc.: annual revenue, USD million, 2009 - 2011
FIG. 19 Swisslog Holding Ltd: annual revenue, USD million, 2009 - 2011

Upcoming Reports:

Pipeline Review Of Rheumatoid Arthritis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. The cause of rheumatoid arthritis is not known. The joint inflammation of rheumatoid arthritis causes swelling, pain, stiffness and redness in the joints. It can lead to a significant loss of mobility due to pain and joint destruction. The disease is also systematic, i.e. it affect extra articular tissues throughout the body. The disease is three times more common in women as in men.Pharmacological treatment of rheumatoid arthritis can be divided into disease-modifying antirheumatic drugs (DMARDs), anti-inflammatory...
Greece: artichokes market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the artichokes market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the artichokes market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Vein Illumination Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Vein illumination device, also known as vein finder, is a biomedical device which uses near infrared light to illuminate subcutaneous veins on skin surface. These devices have applications in hospitals, clinics, private healthcare practices, nursing homes, blood donation centers, ambulances, rehabilitation facilities and academic institutions. These devices are beneficial in case where health problems create difficulties in correct vein identification particularly in elderly patients and for rapid access in emergency situations.  At present, vein illumination devices are...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...